EAACI – JoelGalvan

Business

Intellia Reports Positive 3-Year Lonvo-z Data in HAE Trial at EAACI Congress

2 min read

Posted on June 24, 2025

by Joelgalvan

Intellia Therapeutics, Inc. (NASDAQ:NTLA) is among the 11 Best Genomics Stocks to Buy According to Hedge Funds. It presented encouraging…